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Introduction

31
Due to an increasing demand for rapid, reliable and economical near patient or field testing, over 32 the last few decades there has been a strong trend toward in-vitro point of care (PoC) testing in 33 clinical diagnosis, food safety, environmental monitoring, safety and security [1, 2] . Significant 34 segments of PoC testing are based on bioassays where extremely low concentrations of markers 35 (infectious agents, pesticides, cardiac markers, allergens etc.) need to be identified and 36 distinguished from other matter within small volumes of complex matrices (e.g. whole blood, 37 sputum swabs, faeces, cell lysate…). To meet these needs, PoC in-vitro diagnostic devices are 38 required to provide a fast, sensitive and selective analysis of assays, ideally a simultaneous 39 analysis of multiple assays, and therefore new approaches being explored are often based on 40 highly integrated sensors within a Lab on Chip format [3] . Furthermore, for low cost and practical 41 application by non-technical users, optimal designs negate the need for lengthy off-chip sample 42 preparation. 43 A c c e p t e d M a n u s c r i p t
At the core of these devices is the biosensor [4] and those based on optical interrogation offer 1 important advantages such as: 1) non-invasive, safe and multi-dimensional (intensity, wavelength, 2 phase, polarization) detection; 2) well-established tools from communication and Micro-Nano 3 technologies (MNT) industries (lasers, detectors, waveguides) and 3) optical frequencies that 4 coincide with a wide range of physical properties of bio-related materials. 5
Many optical biosensors are based on refractive index (RI) sensing, where the effective refractive 6 index of the surface of an optical structure is modified by the presence of a target analyte [5] . For 7 the development of photonic biosensors, nanostructured materials like porous silicon (PSi) or 8 porous alumina (AAO) have gained special attention, as they have higher surface areas than 9 planar biosensors for capturing analytes and thus permit lower detection limits [6] . To date, several 10 label-free photonic biosensors have been successfully developed on both PSi [7, 8] and AAO [9, 11 10] porous membranes, using reflectometric interference spectroscopy (RIfS). However, this 12 approach produces slow responses and long sensing times, due to the narrow (<100nm) closed 13 end pores of the membranes used, resulting in analyte delivery being mainly governed by the 14 stationary flux produced by electrostatic interactions. The problem of analyte delivery has been 15 obviated in a fluorescent flow-through assay using a fibrous filter as an improved method for 16 protein capture [11] , however this was as an ex-situ end point assay which after the analyte was 17 bound required the substrate to be dried and transferred to a reader for measurement under index 18 matched liquid. In a recent approach using optical polarimetry [12] , we demonstrated that free 19 standing macroporous AAO membranes with 200nm diameter pores when functionalized with an 20 epoxysilane allow analytes to flow-through them. Due to the pore size, the analyte molecules flow-21 through no more than 100 nm from the assay surface (the pore wall), breaking the mass transport 22 limitations and so effectively targeting their delivery, for real-time biosensing responses, an 23 approach which has also been proposed elsewhere with similar porous optical structures [13, 14] . 24
Here, we report on the use of this approach for immunosensing, by coating the membrane with a 25 functional copolymer, copoly(DMA-NAS), through a novel procedure that has demonstrated less 26 non-specific binding, and therefore greater selectivity, and more stability over time for immobilized 27 allergens than epoxysilane [15] . In this paper, we first detail the procedure for immobilizing the 28 bioreceptors inside the pores of the alumina membrane, including the novel process for coating the 29 pores with the copolymer. After demonstrating the stability of the immobilized allergens, we show a 30 5 times signal enhancement through the use of streptavidin coated quantum dots (SA-QDs) 31 compared to the secondary antibody used. Finally, we show the concentration performance of the 32 immunoassay by using solutions of the first antibody at different concentrations, followed by a fixed 33 concentration of the secondary antibody and streptavidin coated quantum dots. 34
Material and methods
35
Material 36
The free-standing macroporous alumina membranes were purchased from Whatman (Anodisc™ 37 membranes, 13 mm diameter, 200 nm nominal pore diameter, 60 μm thickness and 0. specific Immunoglobulin E (IgEs) in the complex matrix of serum, proving its suitability as a non- 19 fouling coating and that it is robust to allergen storage. 20
For this work it was not possible to coat the surface with poly(DMA-NAS-MAPS) using the usual dip 21
and rinse method, due to the instability of AAO towards some of the reagents used in the 22 procedure, therefore, a functional coating of DMA and NAS was obtained via a novel two step 23 procedure involving modification of the surface with MAPS followed by the grafting of poly(DMA- Before the pore surfaces were coated, the membranes were cleaned with an oxygen plasma for 10 33 minutes in a Harrick Plasma cleaner (Ithaca, NY, USA) and then immersed in a solution of MAPS 34 in toluene (10% v/v). A vacuum was applied for 10 minutes in order to assure that the pores were 35 completely filled with this solution, before the reactor was sealed and left overnight at room 36 temperature. After silanization, the membranes were first washed on a Buchner funnel, under 37 vacuum with toluene and then with THF and finally cured under vacuum at 80°C for 30 minutes. 38
Thereafter, a 20 mL solution of 10% DMA and NAS in DMF (molar ratio 90-10; 1.85 mL, 17.95 mM 39 and 340 mg, 2.01 mM respectively) was prepared. The silanized membranes were then immersed 40 in this solution and an argon purge was used to remove oxygen from the solution for 15 minutes. 41 AIBN (6.5 mg, 2 mM) was then added and a vacuum applied for 10 minutes to assure that the 42 pores were completely filled with the degassed monomer solution and then the reactor was sealed 43 and heated with a silicon bath, at 65°C overnight. Finally, the membranes were washed on a 44
A c c e p t e d M a n u s c r i p t Buchner funnel, under vacuum, first with DMF and then with THF, before being dried under 1 vacuum at room temperature. 2 3
Allergen immobilization 4
The allergen -lactoglobulin was spotted onto the coated membranes using a piezoelectric spotter 5 (Scienion SciFlexArrayer S5). Several droplets of a solution of -lactoglobulin (1mg/mL in PBS) 6
were spotted in the central area of the membranes so as to form a square of 5x5 mm. Membranes 7 were layered on nitrocellulose slides wetted with 10 µL of the same antigen solution, so to assure 8 complete filling of the pores by capillary action. The spotted membranes were then left overnight in 9 a moisture chamber before being rinsed with PBS, on a Buchner funnel, and then treated with a 10 solution of BSA (0.1 mg/mL) to block any remaining active sites of the coating. 11 12 2.3 Membrane transfer to supports 13 After having immobilized the bioreceptors on the functionalized free-standing membranes, in order 14 to conduct flow-through sensing experiments, the circular membranes were first transferred onto 15 mechanical support chips (Figure 2 ). The support chips chosen were 15 by 15 mm pieces of single 16 side polished silicon wafer, 500 μm thick, due to their stability in an aqueous environment as well 17 as the flat interface they provide for a good mechanical contact between them and the membranes. 18 The support chips had a 750 μm diameter opening in the centre which was made using a CO 2 laser, 19 and the edges were chamfered on the reverse side in order to allow the laser light to readily pass 20 through the hole without being occluded by the walls of the support chip. A 1 μm thick layer of 21 PMMA (Poly(methyl methacrylate)) resist was used as the adhesion layer between the alumina 22 membranes and the silicon supports. Support mounted membranes were then stored in a 23 desiccator at 4 °C until they were used in the biosensing experiments. This set-up forms a 750um 24 diameter active spot area and is compatible with a multispot format which would allow multiplexed 25 assays. Smaller spots are also be possible as the measurement sensitivity is in principle not spot 26 size dependent. 27 The readout platform ( Figure 3a ) used a polarimetric setup [19] to interrogate the changes in the 32 optical anisotropy of the macroporous free-standing membranes, the sensing mechanism for the 33 bioassay. Analyte molecules within the pores modify the birefringence which is detected within the 34 setup as a change of phase retardation between the components of light polarized along the main 35 axis directions. Briefly the setup is: the output light from a 980 nm laser diode is first collimated and 36 then directed to a linear polarizer with the resulting linearly polarized light then entering a 37 photoelastic modulator (PEM; Hinds Instruments PEM-100). The modulated light exiting the PEM is 38 then incident at 45º to the planar surface of the alumina membrane, which is mounted on the 39 support chip within a flow-cell. The light exiting the membrane, after passing a second polarizer, is 40 detected by a photodiode which is connected to a lock-in amplifier (SR-830). The lock-in amplifier 41
demodulates the detected signal extracting the amplitudes of its first and second harmonics, which 42 are related to the phase retardation. 43
A c c e p t e d M a n u s c r i p t
The fluidic setup used within the readout platform allows the analytes to be pumped through the 1 flow cell encased and mechanically supported membrane by use of a pressure controller 2 connected to a syringe where the running buffer is stored (Figure 3b ). Before filling with liquid, the 3 system is purged with CO 2 for 5 minutes to ensure complete filling and to reduce the incidence of 4 bubbles. The purging consists of the CO 2 displacing the air in the system and any that is not 5 displaced on filling with solution is then dissolved in the water or buffer. 
27
Results and discussion
1 2
Characterization of AAO membranes 3
The membranes were analyzed by FT-IR after each step of the coating process, to confirm that the 4 chemical modification was taking place as intended. The signals from uncoated membranes (blank 5 samples) were subtracted from the spectra of modified membranes (using Spectra Manager 6 software 1.52 from Jasco, MD, USA) so as to highlight the peaks corresponding to the coating 7 reagents. The subsequent FT-IR spectra of the polymer coated membranes, Figure 5 , show a peak 8 around 1740 cm -1 corresponding to the stretching of carbonyl group of MAPS which increases 9 when NAS is added onto the surface. On coated membranes, as well as the NAS peak, it is 10 possible to observe a peak at 1640 cm -1 which corresponds to the stretching of the DMA carbonyl 11 group. For comparison, an FT-IR (poly(DMA-NAS-MAPS) was also recorded, so as to confirm the 12 presence of the coating on the membrane. 
17
Immunosensing results
18
The activity of the immobilized allergens was tested by running the immunoassay explained in 19 Section 2.5. Figure 6 shows the measured phase retardation when concentrations of 1 μg/mL (6.7 20 nM) are used for the first and secondary antibody and a concentration of 2.5 nM is used for the SA-21 QD. After placing the alumina membrane in the flow-cell and prior to the antibody injections, the 22 baseline obtained during the buffer rinse showed good stability which demonstrated that the 23 antigen is stably immobilized on the polymer coated surface. After recording a stable baseline 24 during six minutes we then injected the first antibody rabbit anti-β-lactoglobulin for a period of 10 25 minutes. Following a six minutes rinse with the running buffer the secondary antibody anti-rabbit 26
IgG was then injected for 10 minutes. As the secondary antibody is polyclonal, a larger response is 27 observed for this, compared to the binding of the initial primary antibody. After further rinsing, the 28 SA-QDs were added as a signal enhancer at a concentration of 2.5 nM, which was sufficient to 29 saturate the captured secondary antibodies. Due to the size of the SA-QDs an enhancement of 5 30 times is observed in the signal over the response produced by the secondary antibody. 31
After this experiment a series of experiments was run using 12 different membranes with the same 32 immunoassay where the concentration of the first antibody was varied between 5 and 1000 ng/mL 33 in order to estimate the detection limit of the system. where SD low_concentration_sample corresponds to the standard deviation obtained from a series of 17 samples at low concentration and LoB is the limit of blank defined as the highest analyte 18 concentration value expected to be obtained for a sample containing no analytes. LoB is equal to: 19
Where mean blank corresponds to the mean value obtained from a series of blank samples and SD 1 corresponds to the standard deviation of the samples. 2
In our case, using β-lactoglobulin as the immobilized antigen, the limit of detection of our system 3 was 33.7ng/ml. This value is chiefly limited by the reproducibility of the mechanical setup rather 4 than the measurement signal noise level, which would establish a limit an order of magnitude lower, 5 at 3.7 ng/mL. For application in clinical allergy diagnostics, a measurement range of 0.84-240 ng/ml 6 (0.35-100 kU/L) is required by clinicians [21] , and thus the presented proof-of-concept system 7 already shows relevant performance for this application. With improvements in the mechanical 8 design and further assay optimization, we expect to improve the detection limit to cover the full 9 range. 10
Compared to previous work employing porous membranes in a flow-over configuration, the flow-11 through configuration applied here enables more efficient convective delivery of analytes to the 12 immobilized recognition molecules. This results in a short total assay time of below 60 minutes for 13 a sandwich assay employing both a secondary and tertiary binding, compared to flow-over assay 14 times of 5 hours for a two-step assay in [8] . Furthermore, in a flow-through configuration the entire 15 sample passes through the membrane in close proximity to the immobilized recognition molecules, 16
and hence the sample utilization is greatly improved. For example, the total analyte containing 17 sample volume consumed during the 10 minute injection in this work was 1 mL, while in [8] a total 18 volume of 50 mL was consumed (100 minute injection at a flow rate of 0.5 mL/min). In terms of 19 analyte mass consumed, the contrast is even more stark, i. 
Conclusions
25
We have demonstrated for the first time a real time immunoassay within a free standing flow-26 through macroporous alumina filter membrane, which provides a route towards rapid and low cost 27 biosensing. 28
Both the stability and the functionality of the coating and spotting procedure were evaluated by 29 injecting inside the pores the antibodies rabbit anti-β-lactoglobulin and anti-rabbit-IgG. The 30 response produced by the binding between the allergen protein and its cognate antibodies was 31 acquired in real-time, by using an optical polarimetric readout platform to measure the anisotropy 32 change of the macroporous alumina membrane. 33
Finally, the use of streptavidin conjugated CdSe quantum dots was investigated as refractive index 34 signal enhancers obtaining five-fold signal amplification compared with the signal produced by the 35 secondary antibody alone. Using this signal amplifier a noise floor for individual measurements of 36 3.7ng/ml (25pM) was obtained, with an overall statistical, or formal assay LOD of 33.7 ng/mL 37 (225pM 
